Leading Edge Genomic Services & Solutions

Novogene unveils intelligent Next Generation Sequencing delivery platform – Falcon

New platform drives industry forward and opens up a new era for NGS technology

Novogene recently announced Falcon, the first intelligent delivery platform for high-throughput Next Generation Sequencing (NGS). This platform represents a breakthrough in traditional NGS and will shape NGS industry standards and drive the future development of the NGS ecosystem. It will provide customers with an intelligent, efficient and robust service to help meet their sequencing requirements.

“Leveraging our years of expertise in genomic sequencing has enabled Novogene to develop and launch the first intelligent multi-product NGS delivery platform, which will provide a cutting-edge sequencing solution for customers. As a safe and accurate one-stop ground-breaking solution, Falcon enables faster delivery with a more stable quality. As a leading provider of genomic services and solutions in the world, we want to be better positioned to drive innovation in the industry, to lead the industry in the direction towards becoming digital and automated, to propel the establishment of industry standards, and to eventually achieve intelligent transformation”, said Dr. Li Ruiqiang, founder and CEO of Novogene.

Setting a new benchmark for NGS with intelligent technologies

Being intelligent is the cornerstone of Falcon. Over the years, NGS has become the mainstream commercial sequencing method thanks to its high throughput, fast sequencing speed, high flexibility and versatility. However, traditional NGS processes require manual or semi-manual operation by lab workers.

Falcon automates and optimizes NGS procedures. It’s designed to eliminate silos and blockages in NGS operations, from sample extraction and quality control to library preparation, library quality control, library pooling, and all the way to bioinformatics analysis.

Through this intelligent automation, Falcon is able to realize the concurrent delivery of four product types (WGS, WES, RNA-seq and library construction) and significantly improve the delivery cycle and data quality. In the future, more product types will be added.

Falcon’s platform is based on efficient data transmission and machine recognition to achieve accurate control, real-time monitoring and dynamic optimization of production, to ensure 24-hour round-the-clock production.

Creating a breakthrough delivery cycle and scale with a higher efficiency

The key advantage of Falcon is efficiency. The fully automated delivery platform processes samples far more efficiently than traditional human-assisted, single-process and semi-automated production lines. It can process 2,000 to 3,000 full-process samples a day, reducing the production cycle by an average of 60%. Its automated design ensures efficient 24-hour operations and guarantees the production cycle of major projects. For example, it takes 16 days from library construction to data delivery for a RNA-seq library construction project for a research institute with 500 standard samples using traditional methods. Falcon can do this in 90 hours.

Falcon can further improve efficiency through workforce management, reducing labor costs by up to 70% and doubling output stability. Through digital innovation, Novogene will unleash staff productivity to focus on developing many more innovative solutions.

Ensuring a reliable quality with a more stable performance

Reliability and stability are at the core of Falcon’s competitiveness. Sample contamination is a major problem affecting the accuracy of sequencing results in NGS. As an intelligent and fully automated production line, Falcon ensures extremely high reliability and stability throughout the process. The platform uses machine analysis to analyze and differentiate samples without human intervention. This avoids contamination in the sequencing process leading to an accuracy of up to 99.99%.

Falcon adopts two quality control steps: one is in the sample extraction step, and the other is in the library quality control step. It automatically chooses and matches the corresponding standards for different products, and simultaneously performs data recognition and diagnosis. All the sequencing results are evaluated by machine to ensure objectivity and effectiveness wherever possible. Combined with a stable production process this helps to increase the pass rate of NGS library construction by 5%.

To ensure full traceability throughout the production process a unique tracking code is generated for each sample. This enables customers to check a project’s progress at any time.

Novogene will continue to migrate more product lines to Falcon. This will be alongside new product launches and upgrading infrastructure to increase throughput and capacity. By leveraging its many years of expertise, Novogene will continue to explore push the boundaries of NGS and help to define industry standards, to strive for breakthroughs in productivity, stability and quality.

About Novogene

Founded in 2011, Novogene is a leading provider of genomics services and solutions in the world. Headquartered in Beijing, Novogene is doing business in over 60 countries and regions across 6 continents, serving over 4,000 clients. As the leader of genomic sequencing industry in China, Novogene provides services for fundamental researches in life sciences, for medical researches and technologies, and for library construction and sequencing platform building. We also provides sequencing, mass spectrometry (MS) and bioinformatics services for research universities, research institutes, hospitals, drug developers, and agricultural enterprises around the world.

As China gets back to work, Novogene announces scaling of sequencing services on Oxford Nanopore PromethION

As researchers from the broad scientific community in China are able to resume their research, Novogene, the global genome sequencing service provider, has announced that it will be scaling up its provision of sequencing services using Oxford Nanopore’s high throughput device, PromethION .

Oxford Nanopore and Novogene will collaborate to expand the types of application available using nanopore sequencing, to take advantage of nanopore’s rich data and ability to sequence short to ultra-long fragments of DNA/RNA. Having performed initial validation and testing on the PromethION in 2019, Novogene will start expanding services on a fleet of three PromethIONs, with a view to scaling up in the future. Novogene will offer applications including de novo genome assembly, bulk and single cell/nucleus full-length transcriptome sequencing, human genome resequencing and metagenomics.

Gordon Sanghera, CEO of Oxford Nanopore said, “We are pleased to support Novogene as a global powerhouse in genomics sequencing service. We are particularly excited to support the flourishing of new applications that take advantage of good value, high yields of longer reads.”

Ruiqiang Li, CEO of Novogene said, “We’re delighted to participate in the construction of the nanopore sequencing application ecosystem. We will keep providing advanced and tailored long-read genomic solutions to our customers based on this collaboration.“

Novogene is a leading provider of genomic services and solutions with cutting edge NGS and bioinformatics expertise, and the most advanced sequencing capacity in the world.

Novogene utilizes scientific excellence, a commitment to customer service and unsurpassed data quality to help our clients realize their research goals. The company has become a world-leader in NGS services, with about 2,400 employees and multiple locations across the globe. Novogene’s depth of experience has resulted in the ownership of 29 NGS-related patents, as well as the publishing of over 517 research papers in collaboration with customers, often in well-respected publications such as Nature and Science.

Oxford Nanopore’s PromethION 48 device offers the only technology capable of sequencing long (or even ultra-long 1Mb +) fragments of DNA. The modular design of the PromethION allows for multiple experiments to be conducted at once, allowing for both scale and flexibility of use. One PromethION device can deliver more than 7 Tb of sequence data in a single run of 48-flow cells.

Novogene 2020 UK Campus Recruiting Events

The Novogene 2020 UK Recruiting Events will be held in March 2020.

We welcome talented individuals who are focused in the life sciences field to register and attend the campus recruiting events.

This will be an excellent opportunity to communicate with the leadership of
Novogene and explore more opportunities for the future.


R&D Management
Bioinformatics
Technical Support
Project Management
Sales & Marketing
Position Responsibility Qualification Location
Bioinformatics Engineer 1. Analyze biological data using various bioinformatics software and statistical methods;
2. Design, develop and maintain various processes of bioinformatics analysis;
3. Analyze project situation and deal with after-sales problems by high-throughput sequencing;
4. Evaluate overseas customer intentions, analyze details and provide solutions;
5. Write technical documents and conduct training
1. Master’s degree in Bioinformatics, Computational Science, Statistic or Genetics, overseas education background is preferred;
2. Proficiency in programming language for bioinformatics (python/perl/R/C/C++/java), and Linux operating system;
3. Proficiency in the basic data structure and algorithm, and statistical methods;
4. Proficiency in the use of bioinformatics tools and database resources;
5. Relevant work experience in high-throughput biochip data analysis, second-generation high-throughput sequencing data analysis and bioinformatics analysis is preferred
10 vacancies in Beijing/Tianjin China
Technical Support 1. Problem solving: communicate with operations and bioinformatics team to address customer concerns and technical problems. This may include issues related to experimental design, sequencing strategy and other pre-sales and after-sales questions;
2. Market information collection: assist sales team to collect information about potential customers and the market;
3. Sales training: arrange training for the sales team and provide professional answer for their questions;
4. Project and follow-up: cooperate with the Project Manager to monitor the project activities and ensure the on-schedule delivery of projects. Keep customers updated of the project status;
5. Payment follow-up: work closely with the sales team to achieve the revenue goals;
6. Documentation record: record, collect and analyze the sales performance, prepare official documents for the sales team (quotation, invoice…);
7. Attend conferences, make presentations and travel with sales team to provide direct scientific guidance to potential customers
1. Fluent English;
2. M.S/PhD plus focus on molecular biology, genetics or other biological related majors;
3. Excellent analytical, problem-solving and interpersonal skills required;
4. Outstanding written and verbal communication and training skills;
5. Must be very detail oriented;
6. Ability to multitask and work under pressure;
Not necessary but would be brilliant:
1. Experience with Next Generation Sequencing technology
2. Experience within a customer facing role in sales or support
10 vacancies in Beijing/Tianjin China; 4 in Cambridge UK
Project Coordinator 1. Follow up the progress of the project and perfect the project information;
2. Grasp the time node of the project and effectively communicate with all departments to ensure the completion of the project within the cycle;
3. Review the reports and accurately give the task list on time;
4. Solve after-sales problems and optimize the project process
1. Major in molecular biology or other biological related majors and solid professional knowledge;
2. Strong English skills in listening, speaking, reading and writing, comprehensive understanding of advances in genomics, and high throughput sequencing experience is preferred;
3. Strong pioneering spirit, excellent communication skills and anti-pressure ability, and good teamwork spirit;
4. Strong sense of responsibility and execution, strong logical thinking ability
6 vacancies in Beijing/Tianjin China; 4 in Cambridge UK
PI 1. Lead team NGS and bioinformatics research, data analysis work oriented by scientific breakthroughs;
2. Top-level design for independent or collaborative research projects and lead team implementation;
3. Build up domestic and abroad cooperation network, keep positive academic exchange;
4. Applications for independent or cooperative research funds
1. PhD degree focus on molecular biology, genetics or other biological related majors; 2. Published at least 1 high-level research papers as one of the first authors, and independently completed high-level English papers writing, modifying, contributing, reviewing, etc;
3. Played a key role in at least one research effort (top design, etc.);
4. At least 2 years NGS data analysis experience;
5. Proficient in Chinese and English
6 vacancies in Beijng/Tianjin China
Sales Manager The Sales Representative’s role is to ensure the achievement of sales within their given territory. The position will be responsible for managing all business accounts in the assigned region, create strategies and execute tactics to develop and implement sales plans that will contribute to the financial growth of the company. Develop, establish and implement an effective sales plan tailored to the territory and specific accounts to achieve the goals of the budget and financial growth of the territory.
1. Maintain a current understanding and knowledge of the company’s products and services to provide accurate information to clients and customers;
2. Manage existing accounts and expand customer base in territory, developing long-term profitable accounts;
3. Participate in all sales activities and attend meetings.
Develop, establish and implement an effective sales plan tailored to the territory and specific accounts to achieve the goals of the budget and financial growth of the territory.
1. M.S required, advanced degree in life science preferred;
2. Strong knowledge of NGS and genomics;
3. 3+ years of life science sales experience; track record of success in selling genomics related technologies or services in academic field;
4. Demonstrated success in generating new customer leads and building a business;
5. Ability to establish long-term customer relation 6. Travel required.
10 vacancies in UK, Germany, France, Italy, Belgium, Nordics Region, Spain
Sales manager-clinical genomics This role is to ensure the achievement of sales in clinical genomics within their given territories. The position will be responsible for managing all business accounts, creating strategies and executing tactics to develop and implement sales plans that will contribute to the financial growth of the company.
1. Develop, establish and implement an effective sales plan to meet the revenue and profit goals
2. Maintain a current understanding and knowledge of the company’s products and services
3. Manage existing accounts and expand customer base in territory, developing long-term profitable accounts
4. Gather and report market and client feedback for internal technical and process improvement
5. Participate in all sales activities and attend company meetings
6. Home office-based and travel required
1. BA or BS required, advanced degree in life science preferred;
2. Strong working knowledge and networks in clinical genomics field;
3. Strong knowledge of NGS and genomics;
4. 3+ years of life science sales experience; track record of success in selling genomics related technologies or services in clinical settings;
5. Demonstrated success in generating new customer leads and building a business;
6. Ability to establish long-term customer relation
6 vacancies in Several European Countries

Biology, Genetics, Bioengineering, Bioinformatics, Biostatistics, Microbiology, Medical Sciences, Pharmacy, Agriculture, Botany, Computer Science, etc



Email your résumé/CV to:hr-overseas@novogene.com
Apply here: https://jinshuju.net/f/uZT8dZ

*Please register or send resume through the official link or Email. The staff will contact you as soon as possible for further position details!


Novogene was founded in 2011 and is headquartered in Beijing China with lo-cations and genomic sequencing labs in the Sacramento US, Cambridge UK,
Singapore, as well as China (Tianjin and Nanjing), delivering sequencing and testing services to the America’s, Europe and the Asia-Pacific region.
Novogene is committed to cutting edge molecular biological technology and
high-performance computing technology in life science and human health,
with the goal of becoming a leading provider of genomic services and solu-tions. Currently, Novogene possesses the advanced NGS sequencing capaci-ties in the world and unsurpassed HPC platform, which has proudly served
over 26,000 customers globally, expanding our business to over 60 countries
and regions.

Novogene Development


Novogene & NanoCellect partner to deliver single cell solutions to China

San Diego, Calif., January 6, 2020 — NanoCellect Biomedical Inc., a leader in the development and manufacture of microfluidic cell sorting solutions for cell-based assays, today announced a distribution and partnership agreement with China-based Novogene to distribute NanoCellect’s WOLF® Cell Sorter, N1 Single-Cell Dispenser, consumables and software in China. In addition, Novogene will be adding the WOLF platform to advance their leading edge genomic services and solutions business.

NanoCellect’s microfluidic solutions allow researchers to analyze and separate biological samples one cell at a time, enabling researchers to isolate cells or populations of interest from the rest of the sample more gently than conventional technology.

“As we expand our distribution of our products globally, Novogene was an obvious choice to partner with in China. Their leading global position providing sequencing and single cell services, combined with their ability to distribute, service and support researchers in China make Novogene an excellent partner for NanoCellect,” said Chris Neary, CEO Of NanoCellect Biomedical, Inc. “As we continue to expand our international distribution channels, we look forward to partnering with Novogene to bring gentle single-cell sorting solutions to their customers and helping to advance research at the cellular level.”

“NanoCellect’s microfluidic cell sorting technology is very innovative, and we’re delighted to be adding their product offerings growing list of technology solutions for our customer base,” said Ruiqiang Li, Ph.D., founder and CEO of Novogene.

For more information about NanoCellect’s and its products, please visit, nanocellect.com. For more information about Novogene, please visit, en.novogene.com.

About NanoCellect Biomedical, Inc.

NanoCellect is a life science tools company that develops and manufactures innovative solutions for cell analysis and sorting based on microfluidic technology. NanoCellect’s WOLF® Cell Sorter and N1 single-cell plate dispenser provide gentle sorting to maintain cell viability. The WOLF® platform is used in a growing list of application areas including antibody discovery, cell line development, genomic sample preparation, CRISPR genomic editing and plant, and animal genomics. Founded in 2009, NanoCellect is headquartered in San Diego, CA. For more information, please visit nanocellect.com.

About Novogene

Novogene is a leading provider of genomic services and solutions with cutting edge NGS and bioinformatics expertise, and more advanced sequencing capacity in the world. Novogene utilizes scientific excellence, a commitment to customer service and unsurpassed data quality to help our clients realize their research goals. The company has become a world-leader in NGS services, with 2,600 employees and multiple locations across the globe. Novogene’s depth of experience has resulted in the ownership of 27 NGS-related patents, as well as the publishing of over 4920 customer research papers, often in well-respected publications such as Nature and Science ,visit en.novogene.com/.

Novogene Europe Relocates its Sequencing Centre to Cambridge Science Park

CAMBRIDGE, UK, Oct 17, 2019 – Novogene Europe has upgraded and relocated its first European Sequencing Centre to TusPark UK’s new Bio-Innovation Centre in the Cambridge Science Park. The grand opening ceremony of Novogene’s new facility was held at 2 pm, 11th October 2019.

The move to the Bio-Innovation Centre has enabled Novogene’s Cambridge Sequencing Centre to expand its operation and continue to provide unsurpassed turnaround times and guaranteed data quality. With a professional team recruited from all over the world, the Centre offers leading-edge Next Generation Sequencing (NGS) services and solutions for all types of projects. The lab is now equipped with a variety of platforms, including an automatic system for library preparation, multiple NovaSeq 6000s and High Performance Computing Clusters. Novogene Cambridge Sequencing Centre is now capable of performing more than 280,000 human WGS analysis per year.

Novogene is a leading provider of genomic services and solutions with cutting edge NGS and bioinformatics expertise, and more advanced sequencing capacity in the world. The Novogene Europe subsidiary was established in 2014 to address the European market for NGS and expand Novogene’s business in Europe. Novogene Europe now provides leading edge services and solutions to customers in over 30 countries in Europe.

Novogene’s comprehensive service offering at its Cambridge Sequencing Centre includes human genome sequencing, plant and animal genome sequencing, transcriptome sequencing, metagenome sequencing, and lanes sequencing. Additional services are planned for the near future enabling Novogene Europe to provide even more optimized solutions for clients based on their research goals.

Ms. Tingting Zhou, the general manager of Novogene Europe, said, “The relocation of Novogene Cambridge Sequencing Centre helps us to improve our services, which is a significant development milestone of Novogene Europe. This means that we can deliver higher levels of NGS services and help our clients to solve the practical problems in their research. Our customers encouraged us to expand our services as we have always been trying to maximize the benefits for our customers. I also believe that our Cambridge Sequencing Centre will continue to thrive.”

“We are delighted to welcome Novogene to the Bio-Innovation Centre,” said Dr. David Chaplin, TusPark UK’s General Manager of the Bio-Innovation Centre. “Emerging technologies like NGS play critical roles in human health, environmental protection, plant and animal breeding and microbial remediation. The relocation of Novogene Cambridge Sequencing Centre is a fantastic new addition to the Cambridge Science Park. It’s our pleasure to establish a long-term relationship and grow together with Novogene.”

About Novogene Europe

Novogene Europe, established in 2014, is a Subsidiary of Novogene. It makes significant contributions to advancing human heath, agriculture, and environmental protection. Over 300 scientific research institutes and biotechnology companies in Europe rely on the powerful technologies and services of Novogene Europe. With leading-edge platforms, well developed bioinformatics pipelines, extensive experience in NGS, and the support from skilled employees, Novogene Europe has become the most competitive NGS provider in Europe.

About Cambridge Science Park

The Cambridge Science Park was established in 1970 by Trinity College – the largest of the colleges of the University of Cambridge. Trinity owns the freehold of the Cambridge Science Park which comprises 1.7 million sq ft of high technology and laboratory buildings set in 152 acres of mature parkland. Today, the Park is home to 7000 people at over 130 companies ranging from exciting start-ups to some of the world’s leading technology businesses.

Contact:

Ms. Tingting Zhou
General Manager
Novogene Europe
tingting.zhou@novogene-europe.com

Dr. Yan Wang
Tuspark UK
Operations Manager
yan.wang@tuspark.co.uk